Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies.
about
Antigenic variation in Plasmodium falciparum: gene organization and regulation of the var multigene familyExported proteins required for virulence and rigidity of Plasmodium falciparum-infected human erythrocytesVar2CSA minimal CSA binding region is located within the N-terminal regionAnalysis of structure and function of the giant protein Pf332 in Plasmodium falciparumPTEX is an essential nexus for protein export in malaria parasitesSir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparumNew var reconstruction algorithm exposes high var sequence diversity in a single geographic location in MaliStructural insight into epitopes in the pregnancy-associated malaria protein VAR2CSAAllelic diversity of the Plasmodium falciparum erythrocyte membrane protein 1 entails variant-specific red cell surface epitopes.Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolatesEvaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women.Immunization with VAR2CSA-DBL5 recombinant protein elicits broadly cross-reactive antibodies to placental Plasmodium falciparum-infected erythrocytes.Subdomain 3 of Plasmodium falciparum VAR2CSA DBL3x is identified as a minimal chondroitin sulfate A-binding region.Advances and challenges in malaria vaccine development.Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates.The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.VAR2CSA signatures of high Plasmodium falciparum parasitemia in the placentaThe antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding siteProspects and Pitfalls of Pregnancy-Associated Malaria Vaccination Based on the Natural Immune Response to Plasmodium falciparum VAR2CSA-Expressing Parasites.Identification of a Major Dimorphic Region in the Functionally Critical N-Terminal ID1 Domain of VAR2CSA.Developmental stage- and cell cycle number-dependent changes in characteristics of Plasmodium falciparum-infected erythrocyte adherence to placental chondroitin-4-sulfate proteoglycan.Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity.Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancy-associated malaria vaccine candidate VAR2CSA.HIV and co-infections.Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure.Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA.Structural basis for binding of Plasmodium falciparum erythrocyte membrane protein 1 to chondroitin sulfate and placental tissue and the influence of protein polymorphisms on binding specificity.Multiplexing detection of IgG against Plasmodium falciparum pregnancy-specific antigens.Strain-transcending Fc-dependent killing of Plasmodium falciparum by merozoite surface protein 2 allele-specific human antibodiesCharacterization of the antibody response against Plasmodium falciparum erythrocyte membrane protein 1 in human volunteers.Characteristics of Plasmodium falciparum-infected-erythrocyte adhesion to chondroitin sulfate.Evaluating antibody functional activity and strain-specificity of vaccine candidates for malaria in pregnancy using in vitro phagocytosis assays.
P2860
Q24672872-954B76D7-8C11-4343-ADD1-818356D9DA38Q27973501-7B84839B-2662-4729-8343-B1D2939E0079Q28744428-36896D4F-B1CA-4F9D-A7E0-53B652E46B86Q28754453-4471EB5B-544F-4E52-97EE-C38A0F9F4AC1Q30042849-235160F9-CFC5-4AE1-82EF-95476B6853B8Q30046035-764D51FC-3803-4A47-9700-872A0C318B11Q30843121-B780AA0E-D338-4414-A6B5-419AE4FE52B0Q33320197-1FC16A2A-4D6E-409C-A60C-FA949ACD4C93Q33813188-67ABD858-309F-4CEC-AA00-7084A5184F7EQ33822296-EF3B3A34-623C-461A-AEF6-0B2F0BC32890Q33826049-63CD43A4-27A2-4B43-A2B0-5FECC63FE23EQ33826076-CF3349F5-61D2-4326-8A1B-A1C0D6459F56Q34042744-862772C6-51F0-400C-AC58-D8C66B49004BQ34145333-EB76063A-3A53-4DCD-B157-2BDB5F681A95Q34161839-4B096FFA-2534-43BD-86F3-B01B66ADB1D6Q34428497-FFC2E16D-381E-4923-8A21-B76E4309E260Q34921119-BE2EB822-9783-46D6-86F5-D4345B3B4ED3Q35088554-B086095E-4ED4-4267-93D4-E8B3BCDA6D64Q35738477-39C0946B-2389-4321-AFEB-1C0662339804Q35783076-4FCFA250-E8C2-4A94-B1B9-7DDAFB61FC83Q35947173-E9704206-6746-4E27-A372-69072A73B1A8Q36190707-5B7C6E7C-9783-426E-BCB0-D1B13F116B9CQ36539548-C43ADB8F-CA90-46FF-BBA0-D6D4D88D6D9EQ36970184-D7E8BFC4-BFC9-4EF0-9304-7C7413ECF2B9Q37191417-FA4BC45E-1908-4AEF-9826-1F466B76B9E3Q37426131-87B80EDB-C7EC-452E-B3B8-5F1570FB6D97Q38300914-6B494ECB-4069-4667-A4C3-D2F066D1AE8BQ40120062-CB369F3E-5985-48B0-A284-9C5A0FC0DBAFQ42102268-B8B92A67-52E6-43FD-8602-D24536247234Q42157454-EE9E13BF-C2D4-419C-8A7F-229F244628C1Q43118729-21587DAD-52F3-4EDB-9AC7-0415DFA60101Q48023771-92AF2DC9-36A3-4A62-B66A-325C1D3E6FF6
P2860
Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Antigenic differences and cons ...... and cross-reactive antibodies.
@en
type
label
Antigenic differences and cons ...... and cross-reactive antibodies.
@en
prefLabel
Antigenic differences and cons ...... and cross-reactive antibodies.
@en
P2093
P2860
P50
P356
P1476
Antigenic differences and cons ...... and cross-reactive antibodies.
@en
P2093
Aphrodite Caragounis
Emily J Mann
Salenna R Elliott
Timothy J Byrne
P2860
P304
P356
10.1086/500145
P407
P577
2006-01-30T00:00:00Z